Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH

S Hikino1, K Ihara, J Yamamoto

  • 1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Pediatric Research
|December 1, 2001
PubMed

Insights

Persistent low insulin-like growth factor-I (IGF-I) levels in extremely preterm infants correlate with slow physical growth. High growth hormone (GH) levels in these infants are linked to severe retinopathy of prematurity.

Area of Science:

  • Neonatology
  • Endocrinology
  • Pediatric Ophthalmology

Background:

  • Growth hormone (GH) and insulin-like growth factor-I (IGF-I) are critical for physical development.
  • Preterm infants, especially those extremely preterm, face unique growth challenges and are at risk for conditions like retinopathy of prematurity (ROP).

Purpose of the Study:

  • To investigate serum GH and IGF-I levels in preterm infants based on gestational age.
  • To assess the relationship between GH, IGF-I, physical growth, and the development of ROP in preterm infants.

Main Methods:

  • Serum GH and IGF-I levels were measured in 81 preterm infants categorized by gestational age (<28 wk, 28–34 wk, and >34 wk).
  • Physical growth and ROP development were monitored.
  • Multivariate analysis was used to identify associations between hormone levels and outcomes.

Main Results:

  • Extremely preterm infants (<28 wk) exhibited significantly higher GH levels at 1 and 2 months compared to those born at 28–34 wk.
  • Serum IGF-I levels remained low in extremely preterm infants but increased in other groups.
  • IGF-I positively correlated with physical growth in very low birth weight infants, while GH did not.
  • High GH levels at 1 month were significantly associated with severe ROP development.

Conclusions:

  • Low serum IGF-I may contribute to the slow physical growth observed in preterm infants.
  • Elevated GH exposure might be a contributing factor to severe retinopathy of prematurity in this population.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...